menopause and tirzepatide Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 How does menopausal hormone therapy

9c), as determined by behavioral testing 48

Glucagon-like peptide-1 agonists for treating obesity in patients with immune-mediated skin diseases

They may also: improve blood sugar control, heart health and kidney function lower the risk of certain cancers support fertility in women with PCOS/PMOS potentially reduce addictive behaviours Weight loss injections may be a great option for people who have difficulty swallowing pills or who often forget to take a daily tablet or capsule

This trial is ongoing and the results will provide robust evidence of the impact of various bariatric surgical procedures on long-term glycaemic control and T2DM remission [35, 36]

PMID: 20729621)

By integrating both API and formulation development in-house, we are able to maintain greater control across the entire value chain from development through to commercialization, while ensuring a reliable and consistent supply of this important therapy for patients in Canada